Correspondence 0001437749-25-037875 from GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc.
Date: Dec. 15, 2025 · CIK: 0000832489 · Accession: 0001437749-25-037875
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288085, 333-292127
Letter
govx20251215c_corresp.htm
GeoVax Labs, Inc.
1900 Lake Park Drive
Suite 380
Smyrna, Georgia 30080
(678) 384-7220
December 15, 2025
VIA EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Re:
GeoVax Labs, Inc.
Registration Statement on Form S-1
File No. 333-288085
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-292127) filed with the U.S. Securities and Exchange Commission on December 12, 2025, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Wednesday, December 17, 2025 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act.
If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.
Very truly yours,
GeoVax Labs, Inc..
Show Raw Text
CORRESP 1 filename1.htm govx20251215c_corresp.htm GeoVax Labs, Inc. 1900 Lake Park Drive Suite 380 Smyrna, Georgia 30080 (678) 384-7220 December 15, 2025 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 File No. 333-288085 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-292127) filed with the U.S. Securities and Exchange Commission on December 12, 2025, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Wednesday, December 17, 2025 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act. If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com. Very truly yours, GeoVax Labs, Inc.. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer